OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 6

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 40.2% 1,676,745 4,165,987 31.8% 8.4%
Sex Female 39.5% 768,250 1,947,260 31.4% 8.0%
Male 40.9% 908,495 2,218,727 32.2% 8.8%
Ethnicity White - British 43.3% 960,484 2,218,874 34.2% 9.1%
White - Irish 39.3% 8,001 20,356 32.8% 6.5%
White - Any other White background 30.4% 64,309 211,309 24.0% 6.4%
Mixed - White and Black Caribbean 26.9% 3,738 13,881 21.1% 5.8%
Mixed - White and Black African 29.2% 3,066 10,500 23.1% 6.1%
Mixed - White and Asian 35.7% 3,143 8,806 27.8% 7.9%
Mixed - Any other mixed background 31.0% 5,313 17,122 24.6% 6.5%
Asian or Asian British - Indian 40.6% 43,813 107,912 33.8% 6.8%
Asian or Asian British - Pakistani 32.1% 32,263 100,506 25.2% 6.9%
Asian or Asian British - Bangladeshi 38.3% 12,446 32,494 30.0% 8.3%
Asian or Asian British - Any other Asian background 36.5% 22,736 62,321 30.1% 6.4%
Black or Black British - Caribbean 26.0% 8,883 34,167 21.5% 4.5%
Black or Black British - African 26.3% 15,995 60,851 21.2% 5.1%
Black or Black British - Any other Black background 25.2% 4,606 18,270 20.4% 4.8%
Other ethnic groups - Chinese 36.0% 5,159 14,315 27.3% 8.8%
Other ethnic groups - Any other ethnic group 30.9% 11,585 37,485 24.5% 6.4%
Patients with any other ethnicity code 40.0% 214,788 536,438 31.7% 8.3%
Ethnicity not given - patient refused NaN 0 0 NaN NaN
Ethnicity not stated 38.4% 10,682 27,797 29.4% 9.0%
Ethnicity not recorded 38.8% 245,644 632,478 30.4% 8.4%
Ethnicity (broad categories) White 42.1% 1,032,808 2,450,553 33.3% 8.9%
Mixed 30.3% 15,267 50,337 23.9% 6.4%
South Asian 36.7% 111,279 303,254 29.8% 6.9%
Black 26.0% 29,498 113,302 21.2% 4.9%
Other 32.3% 16,751 51,800 25.3% 7.1%
Unknown 39.4% 471,121 1,196,727 31.0% 8.4%
Index of Multiple Deprivation 1 (most deprived) 36.5% 351,407 963,774 28.1% 8.4%
2 39.0% 344,029 882,462 30.5% 8.4%
3 41.2% 337,876 820,379 33.0% 8.1%
4 42.6% 321,559 755,132 34.2% 8.4%
5 (least deprived) 43.5% 306,845 705,012 34.8% 8.7%
Unknown 38.3% 15,015 39,200 29.7% 8.6%
Clinical Risk Groups Patients in Any Clinical Risk Group 40.2% 1,676,759 4,165,987 31.8% 8.4%
Patients with Immunosuppression 41.2% 96,978 235,382 33.3% 7.9%
Patients with CKD 43.3% 92,316 213,234 36.4% 6.9%
Patients who have Chronic Respiratory Disease 39.5% 147,728 374,311 31.2% 8.3%
Patients with Diabetes 42.9% 430,388 1,004,045 36.3% 6.6%
Patients with Chronic Liver disease 37.8% 186,088 491,729 28.6% 9.2%
Patients with CNS Disease (including Stroke/TIA) 40.5% 336,154 829,801 31.5% 9.0%
Patients with Chronic heart disease 42.0% 460,068 1,095,682 33.3% 8.7%
Patients with Asplenia or Dysfunction of the Spleen 40.9% 56,049 137,039 32.0% 8.9%
Patients with Wider Learning Disability 45.5% 73,178 160,930 38.2% 7.3%
Patients with Severe Mental Health 34.9% 114,163 327,523 26.5% 8.3%
Other Groups Patients with Morbid Obesity 44.8% 99,344 221,683 36.6% 8.2%
Patients who are pregnant 10.6% 3,304 31,262 7.4% 3.2%